Cargando...
Head and Neck Cancer Immunotherapy beyond the Checkpoint Blockade
The success of immune checkpoint receptor blockade has brought exciting promises for the treatment of head and neck squamous cell carcinoma (HNSCC). While patients who respond to checkpoint inhibitors tend to develop a durable response, <15% of patients with HNSCC respond to immune checkpoint inh...
Gardado en:
| Publicado en: | J Dent Res |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
SAGE Publications
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6704427/ https://ncbi.nlm.nih.gov/pubmed/31340724 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0022034519864112 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|